There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and seven have been approved for emergency or full use in parts of Europe, North America, and Asia. In the United States, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Register for 5/26, 12pm CTSA Webinar: What Biomedicine Can Learn about Reproducibility from Social & Behavioral Research
- This mom had a cervical cancer tumor the size of a baby’s head. A clinical trial saved her life.
- NJ ACTS K12 Request for Applications Open!
- Should New York City Burn Its Parks? This Scientist Thinks So.
- NJACTS Community Engagement Core Available Services
Categories
- Community (2,486)
- Covid (999)
- CTO Events (6)
- News (3,154)
- Pilots (21)